|
Aggregation
Citations 41-50 of 109 total displayed.
|
Past content
(since Sep 2000):
|
- Vascular Medicine
Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis
- Andrew J. Leger, Suzanne L. Jacques, Jehangir Badar, Nicole C. Kaneider, Claudia K. Derian, Patricia Andrade-Gordon, Lidija Covic, and Athan Kuliopulos
Circulation 2006;113:1244-1254; published online before print as doi:10.1161/CIRCULATIONAHA.105.587758
[Abstract]
[Full text]
- Articles
Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis
- Andrew J. Leger, Suzanne L. Jacques, Jehangir Badar, Nicole C. Kaneider, Claudia K. Derian, Patricia Andrade-Gordon, Lidija Covic, and Athan Kuliopulos
Circulation published February 27, 2006, doi:10.1161/CIRCULATIONAHA.105.587758
[Abstract]
- Interventional Cardiology
Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel: Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial
- Nicolas von Beckerath, Dirk Taubert, Gisela Pogatsa-Murray, Edgar Schömig, Adnan Kastrati, and Albert Schömig
Circulation 2005;112:2946-2950; published online before print as doi:10.1161/CIRCULATIONAHA.105.559088
[Abstract]
[Full text]
- Articles
Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel. Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial
- Nicolas von Beckerath, Dirk Taubert, Gisela Pogatsa-Murray, Edgar Schömig, Adnan Kastrati, and Albert Schömig
Circulation published October 31, 2005, doi:10.1161/CIRCULATIONAHA.105.559088
[Abstract]
- Basic Science for Clinicians
Molecular Regulation of Platelet-Dependent Thrombosis
- Jane E. Freedman
Circulation 2005;112:2725-2734, doi:10.1161/CIRCULATIONAHA.104.494468
[Abstract]
[Full text]
- Stroke
Platelet Adhesion Via Glycoprotein IIb Integrin Is Critical for Atheroprogression and Focal Cerebral Ischemia: An In Vivo Study in Mice Lacking Glycoprotein IIb
- Steffen Massberg, Katrin Schürzinger, Michael Lorenz, Ildiko Konrad, Christian Schulz, Nikolaus Plesnila, Elisabeth Kennerknecht, Martina Rudelius, Susanne Sauer, Siegmund Braun, Elisabeth Kremmer, Nikla R. Emambokus, Jon Frampton, and Meinrad Gawaz
Circulation 2005;112:1180-1188; published online before print as doi:10.1161/CIRCULATIONAHA.105.539221
[Abstract]
[Full text]
- Editorials
To the Heart of the Matter: Coxibs, Smoking, and Cardiovascular Risk
- Matthias Hermann, Henry Krum, and Frank Ruschitzka
Circulation 2005;112:941-945, doi:10.1161/CIRCULATIONAHA.105.567842
[Full text]
- Articles
Platelet Adhesion Via Glycoprotein IIb Integrin Is Critical for Atheroprogression and Focal Cerebral Ischemia. An In Vivo Study in Mice Lacking Glycoprotein IIb
- Steffen Massberg, Katrin Schürzinger, Michael Lorenz, Ildiko Konrad, Christian Schulz, Nikolaus Plesnila, Elisabeth Kennerknecht, Martina Rudelius, Susanne Sauer, Siegmund Braun, Elisabeth Kremmer, Nikla R. Emambokus, Jon Frampton, and Meinrad Gawaz
Circulation published August 15, 2005, doi:10.1161/CIRCULATIONAHA.105.539221
[Abstract]
- Special Reports
Cyclooxygenase Inhibition and Cardiovascular Risk
- Elliott M. Antman, David DeMets, and Joseph Loscalzo
Circulation 2005;112:759-770, doi:10.1161/CIRCULATIONAHA.105.568451
[Full text]
- Correspondence
Letters Regarding Article by Mehilli et al, "Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel" • Response
- Áurea J. Chaves, Amanda G.M.R. Sousa, John W. Eikelboom, James M. Rankin, Adnan Kastrati, Julinda Mehilli, Helmut Schühlen, Alban Dibra, Jürgen Pache, Albert Schömig, Nicolas von Beckerath, Hildegard Bollwein, Josef Dirschinger, Franz Dotzer, and Peter P. Berger
Circulation 2005;111:e370-371e, doi:10.1161/CIRCULATIONAHA.104.529735
[Full text]
|
|
